DCTH

12.67

0.48% 0.06

Handel nachbörslich: 12.66 -0.010 -0.08%

Delcath Systems Inc (DCTH)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

$12.61

Offen:

$12.85

24-Stunden-Volumen:

348.73K

Relative Volume:

0.92

Marktkapitalisierung:

$418.35M

Einnahmen:

$2.07M

Nettoeinkommen (Verlust:

$-47.68M

KGV:

-4.4929

EPS:

-2.82

Netto-Cashflow:

$-31.31M

1W Leistung:

+5.94%

1M Leistung:

+6.83%

6M Leistung:

+60.18%

1J Leistung:

+209.02%

1-Tages-Spanne:

$12.37

$12.85

1-Wochen-Bereich:

$11.19

$12.85

52-Wochen-Spanne:

$3.70

$13.30

Delcath Systems Inc Stock (DCTH) Company Profile

Firmenname

Delcath Systems Inc

Sektor

Healthcare (1174)

Branche

Medical Devices (149)

Telefon

(518) 743-8892

Adresse

566 QUEENSBURY AVENUE, QUEENSBURY, NY

Mitarbeiter

Twitter

@delcathsystems

Nächster Verdiensttermin

2024-11-08

Neueste SEC-Einreichungen

DCTH's Discussions on Twitter

Vergleichen Sie DCTH mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
DCTH Delcath Systems Inc	12.67	418.35M	2.07M	-47.68M	-31.31M	-2.82
ABT Abbott Laboratories	113.83	197.43B	41.22B	5.77B	6.49B	3.29
SYK Stryker Corp	361.52	137.82B	21.97B	3.59B	3.21B	9.33
BSX Boston Scientific Corp	90.69	133.66B	15.91B	1.79B	1.89B	1.21
MDT Medtronic Plc	80.95	103.80B	33.00B	4.29B	5.50B	3.27
EW Edwards Lifesciences Corp	73.91	43.59B	6.60B	4.16B	490.10M	6.93

Delcath Systems Inc Stock (DCTH) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2024-06-28	Eingeleitet	Craig Hallum	Buy
2024-05-14	Eingeleitet	Stephens	Overweight
2022-07-26	Fortgesetzt	Canaccord Genuity	Buy
2021-12-10	Eingeleitet	H.C. Wainwright	Buy
2021-03-09	Eingeleitet	Canaccord Genuity	Buy
2021-01-05	Eingeleitet	BTIG Research	Buy
2020-06-01	Eingeleitet	Laidlaw	Buy

Alle ansehen

Delcath Systems Inc Aktie (DCTH) Neueste Nachrichten

Jan 03, 2025

Delcath Systems Awards 30,000 Stock Options to New Employee at $12.04 Per Share - StockTitan

Jan 03, 2025

State Street Corp Buys 9,400 Shares of Delcath Systems, Inc. (NASDAQ:DCTH) - Defense World

Jan 03, 2025

Jan 01, 2025

Delcath Systems, Inc. (NASDAQ:DCTH) Short Interest Update - MarketBeat

Jan 01, 2025

Wall Street Analysts Believe Delcath Systems (DCTH) Could Rally 96.84%: Here's is How to Trade - MSN

Jan 01, 2025

Delcath Systems raises additional USD 16.3M in funding - Medical Buyer

Jan 01, 2025

Dec 31, 2024

Delcath Systems announces additional $16.3 million in funding from warrant exercises - MSN

Dec 31, 2024

Delcath Systems (NASDAQ: DCTH) Announces Recent Funding and Warrant AmendmentsQueensbury, New York, December 30, 2024 – Delcath Systems, Inc. (NASDAQ: DCTH) recently disclosed important financial developments through an 8-K filing with th - Defense World

Dec 31, 2024

Dec 30, 2024

Delcath secures $16.3 million from warrant exercises By Investing.com - Investing.com Nigeria

Dec 30, 2024

Delcath Systems Secures $16.3 Million in Funding Through Warrant Exercise to Propel Growth in Oncology Treatments - Tandav Media

Dec 30, 2024

Delcath secures $16.3 million from warrant exercises - Investing.com India

Dec 30, 2024

Delcath Systems Secures $16.3M from Warrant Exercise - TipRanks

Dec 30, 2024

Delcath Systems Raises $16.3M Through Warrant Exercise to Advance HEPZATO Melanoma Treatment - StockTitan

Dec 30, 2024

3 US Growth Companies To Watch With Up To 32% Insider Ownership - Simply Wall St

Dec 30, 2024

Dec 29, 2024

(DCTH) Technical Data - Stock Traders Daily

Dec 29, 2024

Analysts Expect Breakeven For Delcath Systems, Inc. (NASDAQ:DCTH) Before Long - Yahoo Finance

Dec 29, 2024

Dec 19, 2024

Does Delcath Systems (NASDAQ:DCTH) Have A Healthy Balance Sheet? - Simply Wall St

Dec 19, 2024

Where are the Opportunities in (DCTH) - Stock Traders Daily

Dec 19, 2024

Dec 16, 2024

Delcath Systems stock soars to 52-week high of $12.99 - Investing.com

Dec 16, 2024

Dec 15, 2024

Positive Preliminary Results from Delcath Systems’ FOCUS Trial Presented at the 2021 ASCO Annual Meeting - Marketscreener.com

Dec 15, 2024

Dec 13, 2024

Clear Street initiates Buy on Delcath Systems stock, highlights profitability potential - Investing.com

Dec 13, 2024

Dec 10, 2024

Thinking about buying stock in Nikola, Delcath Systems, Taysha G - GuruFocus.com

Dec 10, 2024

Dec 09, 2024

Uveal melanoma Treatment Market: Segmentation Trends, - openPR

Dec 09, 2024

Dec 08, 2024

When (DCTH) Moves Investors should Listen - Stock Traders Daily

Dec 08, 2024

Dec 06, 2024

Polar Asset Management Partners Inc. Purchases New Position in Delcath Systems, Inc. (NASDAQ:DCTH) - MarketBeat

Dec 06, 2024

Dec 03, 2024

Delcath to trial Hepzato drug device combo in colorectal cancer - Yahoo Finance

Dec 03, 2024

Dec 02, 2024

FDA finishes review of Delcath’s IND application of HEPZATO combo trial - TipRanks

Dec 02, 2024

Delcath Secures FDA Clearance for Phase 2 Trial of HEPZATO in Colorectal Cancer - StockTitan

Dec 02, 2024

Delcath Systems (NASDAQ:DCTH) jumps 13% this week, taking one-year gains to 330% - Yahoo Finance

Dec 02, 2024

Nov 29, 2024